Nystatin Market Report 2025 (Global Edition)

Global Nystatin Market Report 2025 Market Size Split by Type Outlook: (USP Grade, Research Grade, Other), by Application Outlook: (Skin, Oral Cavity, Other), by End use Outlook: (Adult, Children)

Nystatin Market Report Description

We have various report editions of Nystatin Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Competitive Landscape of the Nystatin Market

The Nystatin market is competitive, with numerous international and regional pharmaceutical corporations concerned with its production. Key gamers encompass groups like Mylan Pharmaceuticals, Novartis, and Sandoz, offering prevalent variations of Nystatin. Competition is based on elements including drug efficacy, price effectiveness, emblem reputation, and distribution networks. The marketplace is also motivated by regulatory approvals and the creation of recent antifungal treatments, impacting Nystatin's market proportion.

In October 2023, Gravitas Therapeutics sells GR-2397, a clinical-stage antifungal drug, to Basilea Pharmaceutica. It has finished a phase 1 research and is now marketed as BAL2062, which targets invasive mold infections. Preclinical profiling is planned by Basilea, with a phase 2 objective by H1 2025. Two million dollars is the upfront payment..

(Source:https://www.basilea.com/news/news?tx_news_pi1%5Baction%5D=detail&tx_news_pi1%5Bcontroller%5D=News&tx_news_pi1%5Bnews%5D=1460&type=1546938654&cHash=9cfb242268abd4d20e613d02ccd9502f/)

In June 2024, Through its Series B round, New York-based biotech company Elion Therapeutics raised USD 81 million in funding. The money is especially intended to further SF001, an early-stage polyene antifungal treatment.

(Source:https://www.prnewswire.com/news-releases/elion-therapeutics-closes-81-million-series-b-funding-round-led-by-deerfield-management-and-amr-action-fund-302174159.html/)

Top Companies Market Share in Nystatin Industry: (In no particular order of Rank)

• Pure Chemistry Scientific
• LGM Pharma
• BOC Sciences
• Toronto Research Chemicals
• J & K SCIENTIFIC
• BeiJing Hwrk Chemicals.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Nystatin Market

Which Region Dominates the Nystatin Market in 2024?

According to Cognitive Market Research, North America currently dominates the Nystatins market, and the region is expected to have significant growth during the projected period. The Nystatin market in North America is growing due to increasing instances of fungal infections, specifically among immunocompromised populations. The vicinity's well-established healthcare infrastructure, growing awareness, and affordability of Nystatin contribute to its huge use. Additionally, the developing consciousness of reachable treatment options and the availability of commonplace formulations are driving market expansion across developed and underserved regions.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The Nystatin marketplace in the Asia Pacific is growing due to growing fungal infection cases, especially in emerging economies with expanding healthcare rights of entry. Increasing attention to fungal diseases, coupled with the affordability of Nystatin, drives its call for in each city and rural region. The area's ageing population, in conjunction with a growing burden of immunocompromised conditions, further hastens market growth.

The current report Scope analyzes Nystatin Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America Nystatin Market Analysis

According to Cognitive Market Research, the global Nystatin market size was estimated at USD 320.1 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 232.64 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.4% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Nystatin market with a market size of USD 183.55 million in 2024 and is projected to grow at a CAGR of 3.2% during the forecast period. The U.S. market's rising fungal infections.
• The Canada Nystatin market had a market share of USD 27.92 million in 2024 and is projected to grow at a CAGR of 4.2% during the forecast period. Canada’s increasing geriatric population.
• The Mexico Nystatin market is projected to witness growth at a CAGR of 3.9% during the forecast period, with a market size of USD 21.17 million in 2024.

Europe Nystatin Market Analysis

According to Cognitive Market Research, the global Nystatin market size was estimated at USD 235.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 174.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2031.

• The United Kingdom Nystatin market had a market share of USD 29.31 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. In the UK, Nystatin sales witness an upswing due to the expanding pharmaceutical industry.
• The France Nystatin market is projected to witness growth at a CAGR of 2.9% during the forecast period, with a market size of USD 16.05 million in 2024.
• According to Cognitive Market Research, the German Nystatin market size was valued at USD 34.55 million in 2024 and is projected to grow at a CAGR of 3.9% during the forecast period. In Germany, Nystatin surged due to the healthcare awareness.
• The Italy Nystatin market is projected to witness growth at a CAGR of 3.1% during the forecast period, with a market size of USD 15.01 million in 2024.
• The Russia Nystatin market is projected to witness growth at a CAGR of 2.7% during the forecast period, with a market size of USD 27.04 million in 2024.
• The Spain Nystatin market is projected to witness growth at a CAGR of 2.8% during the forecast period with a market size of USD 14.31 million in 2024
• The Luxembourg Nystatin market is projected to witness growth at a CAGR of 3.8% during the forecast period, with a market size of USD 5.41 million in 2024.
• The Portugal Nystatin market is projected to witness grow6th at a CAGR of 3.6% during the forecast period, with a market size of USD 3.6 million in 2024.
• The Greece Nystatin market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 2.09 million in 2024.
• The Rest of Europe's Nystatin market is projected to witness growth at a CAGR of 2.4% during the forecast period, with a market size of USD 27.04 million in 2024.

Asia Pacific Nystatin Market Analysis

According to Cognitive Market Research, the global Nystatin market size was estimated at USD 212.3 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 133.77 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.

• According to Cognitive Market Research, the China Nystatin market size was valued at USD 60.20 million in 2024 and is projected to grow at a CAGR of 6.7% during the forecast period. Nystatin surged in China due to OTC medication growth.
• The Japan Nystatin market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 18.46million in 2024.
• The India Nystatin market had a market share of USD 16.05 million in 2024 and is projected to grow at a CAGR of 9.0% during the forecast period. India's r&d advancements.
• The South Korean Nystatin market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 13.38 million in 2024.
• The Australian Nystatin market is projected to witness growth at a CAGR of 6.9% during the forecast period, with a market size of USD 6.96 million in 2024.
• The South East Asia Nystatin market is projected to witness growth at a CAGR of 8.2% during the forecast period, with a market size of USD 9.23 million in 2024.
• The Rest of Asia Pacific Nystatin market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 9.50 million in 2024.

South America Nystatin Market Analysis

According to Cognitive Market Research, the global Nystatin market size was estimated at USD 44.0 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 29.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.6% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Nystatin market size was valued at USD 12.45 million in 2024 and is projected to grow at a CAGR of 5.2% during the forecast period. Nystatins flourished in Brazil due to improved healthcare access.
• Argentina's Nystatin market had a market share of USD 4.89 million in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period. Argentina's e-commerce growth.
• Colombia Nystatin market is projected to witness growth at a CAGR of 4.4% during the forecast period, with a market size of USD 2.59 million in 2024.
• Peru Nystatin market is projected to witness growth at a CAGR of 4.8% during the forecast period, with a market size of USD 2.38 million in 2024.
• Chile Nystatin market is projected to witness growth at a CAGR of 4.9% during the forecast period, with a market size of USD 2.09 million in 2024.
• The Rest of Latin America's Nystatin market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 4.68 million in 2024.

Middle East Nystatin Market Analysis

According to Cognitive Market Research, the global Nystatin market size was estimated at USD 17.4 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 11.63 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031..

• The GCC Countries Nystatin market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 4.98 million in 2024. Nystatin sales flourish due to the preventive healthcare focus.
• The Egypt Nystatin market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 1.22 million in 2024.
• The South Africa Nystatin market is projected to witness growth at a CAGR of 5.9% during the forecast period, with a market size of USD 1.84 million in 2024. Nystatin sales flourished in South Africa due to urbanization trends.
• The Turkey Nystatin market is projected to witness growth at a CAGR of 4.4% during the forecast period, with a market size of USD 1.00 million in 2024.
• The Nigeria Nystatin market is projected to witness growth at a CAGR of 4.0% during the forecast period, with a market size of USD 1.22 million in 2024.
• The Rest of the MEA Nystatin market is projected to witness growth at a CAGR of 3.9% during the forecast period, with a market size of USD 1.37 million in 2024.

Nystatin Market Analysis

How are Segments Performing in the Global Nystatin Market?

Nystatin Market Type Segment Analysis

According to Cognitive Market Research, USP Grade are likely to dominate the Nystatin Market over the forecast period. The demand for USP-grade Nystatin is contributing to the growth of the Nystatin market, in particular in prescribed drugs and healthcare settings. USP-grade Nystatin meets excessive requirements of purity, safety, and efficacy, making it suitable for essential clinical treatments. Its use in hospitals and healthcare centres for treating fungal infections, mixed with growing regulatory requirements, is driving the market's expansion.

The Research Grade is the fastest-growing segment in the Nystatin Market.The growing demand for research-grade Nystatin is fueling market growth, specifically in the pharmaceutical and biotechnology sectors. Research-grade Nystatin is utilized in laboratory settings for research on fungal infections, drug resistance, and antifungal efficacy. As the focus on microbiome studies and the improvement of novel antifungal treatments increases, the demand for extremely good, research-grade Nystatin is riding market growth .

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Nystatin Industry. Request a Free Sample PDF!

Nystatin Market Application Segment Analysis

According to Cognitive Market Research, the Skin segment holds the largest share of the market. The increasing incidence of pores and skin fungal infections is contributing to the growth of the Nystatin marketplace. Nystatin's effectiveness in treating skin situations, including Candida infections, rashes, and diaper dermatitis, is driving the demand for it. With growing recognition of dermatological health and the provision of Nystatin in a topical bureaucracy like creams and ointments, the market for skin-associated treatments continues to increase.

In the Nystatin Market, the Oral Cavity has been expanding at a rapid pace. The Nystatin market is developing in the oral cavity segment because of the rising prevalence of oral fungal infections, specifically Candida infections and thrush. Nystatin, available in oral suspension and pill form, is a preferred remedy due to its effectiveness and safety. Increased recognition of oral fitness and easy access to cheap remedies are also boosting marketplace demand for this product.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Nystatin End use Outlook: Segment Analysis

Nystatin Market End use Segment Analysis

According to Cognitive Market Research, Adult segment holds the largest market share. The Nystatin marketplace is developing in adults, specifically among those with weakened immune structures, including people with diabetes, most cancers, or HIV. Adult patients are extra prone to fungal infections like oral thrush and pores and skin situations, using call for Nystatin. The medicine's affordability, effectiveness, and protection profile make it a popular choice for treating those common grownup fungal infections.

In the Nystatin market, the rapidly growing sector is the Children. The Nystatin market is developing among youngsters, particularly for treating fungal infections like oral thrush and diaper rashes. Due to its safety profile and effectiveness, Nystatin is broadly prescribed for pediatric patients. Increased awareness of fungal infections in children, together with a focus on low-cost treatment alternatives, is driving.

• Adult
• Children

Author's Detail

Aarti Bagekari

Research Associate at Cognitive Market Research

LinkedIn

Profile

I am Aarti Bagekari, worked as a research associate with strong passion for transforming complex information into strategic insights. My strong analytical skills, coupled with a deep understanding of market dynamics and consumer behavior, empower me to identify hidden opportunities and proactively mitigate risks for clients. As a part of team, I possess a skills in data analysis, segmentation, competitive landscape.

Author's Conclusion